Morphine alters macrophage and lymphocyte populations in the spleen and peritoneal cavity

被引:27
作者
Hilburger, ME
Adler, MW
Rogers, TJ
Eisenstein, TK
机构
[1] TEMPLE UNIV, SCH MED, DEPT MICROBIOL & IMMUNOL, PHILADELPHIA, PA 19140 USA
[2] TEMPLE UNIV, SCH MED, DEPT PHARMACOL, PHILADELPHIA, PA 19140 USA
关键词
immunomodulation; morphine; lymphocyte; macrophage; flow cytometry; opioids;
D O I
10.1016/S0165-5728(97)00142-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have previously shown that subcutaneous implantation of a 75 mg morphine pellet results in suppression of the ability of murine splenocytes to mount an antibody response to sheep I ed blood cells, due in part to a reduction of macrophage function. The present studies used flow cytometry to examine whether the decrement in macrophage function in the spleens of morphine-treated mice results from a reduction in macrophage numbers. Parallel analysis was carried out on non-elicited peritoneal cells. In the spleen, morphine resulted in a reduction in the relative proportion of macrophages and B-cells, with a concomitant increase in the proportion of T-cells. Alteration in the ratio of CD4(+) to CD8(+) T-cells was not observed. In contrast, in the peritoneal cavity, morphine increased the number of macrophages and reduced the number of B-cell. Naltrexone blocked all of the chan:es in cellular composition. There results support the conclusion that an important mechanism in the immunosuppression seen in the spleens of mice implanted with morphine pellets is a differential reduction in the number of macrophages and B-cells as compared with T-cells. Further, these studies show that subsets of cells of the immune system are differentially affected by morphine in different anatomical compartments. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:106 / 114
页数:9
相关论文
共 45 条
  • [1] Armitage P., 2001, STAT METHODS MED RES, V4th
  • [2] MORPHINE-INDUCED IMMUNE ALTERATIONS INVIVO
    ARORA, PK
    FRIDE, E
    PETITTO, J
    WAGGIE, K
    SKOLNICK, P
    [J]. CELLULAR IMMUNOLOGY, 1990, 126 (02) : 343 - 353
  • [3] F4-80, A MONOCLONAL-ANTIBODY DIRECTED SPECIFICALLY AGAINST THE MOUSE MACROPHAGE
    AUSTYN, JM
    GORDON, S
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (10) : 805 - 815
  • [4] MORPHINE-INHIBITION OF LYMPHOCYTE ACTIVITY IS MEDIATED BY AN OPIOID DEPENDENT MECHANISM
    BAYER, BM
    DAUSSIN, S
    HERNANDEZ, M
    IRVIN, L
    [J]. NEUROPHARMACOLOGY, 1990, 29 (04) : 369 - 374
  • [5] DISTINCTION BETWEEN THE INVITRO AND INVIVO INHIBITORY EFFECTS OF MORPHINE ON LYMPHOCYTE-PROLIFERATION BASED ON AGONIST SENSITIVITY AND NALTREXONE REVERSIBILITY
    BAYER, BM
    GASTONGUAY, MR
    HERNANDEZ, MC
    [J]. IMMUNOPHARMACOLOGY, 1992, 23 (02): : 117 - 124
  • [6] BRYANT HU, 1988, J PHARMACOL EXP THER, V245, P913
  • [7] IMMUNOSUPPRESSIVE EFFECTS OF CHRONIC MORPHINE TREATMENT IN MICE
    BRYANT, HU
    BERNTON, EW
    HOLADAY, JW
    [J]. LIFE SCIENCES, 1987, 41 (14) : 1731 - 1738
  • [8] DIFFERENTIAL-EFFECTS OF MORPHINE AND NALTREXONE ON THE ANTIBODY-RESPONSE IN VARIOUS MOUSE STRAINS
    BUSSIERE, JL
    ADLER, MW
    ROGERS, TJ
    EISENSTEIN, TK
    [J]. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 1992, 14 (03) : 657 - 673
  • [9] BUSSIERE JL, 1993, J PHARMACOL EXP THER, V264, P591
  • [10] BUSSIERE JL, 1992, LIFE SCI, V52, pPL43